Trials / Conditions / Recurrent Lung Carcinoma

Recurrent Lung Carcinoma

6 registered clinical trials studyying Recurrent Lung Carcinoma.

Status	Trial	Sponsor	Phase
Withdrawn	Testing of TAK228 (MLN0128, Sapanisertib) Plus Docetaxel to the Usual Standard of Care for Advanced Squamous C NCT04267913	SWOG Cancer Research Network	Phase 2
Completed	Embedded Palliative Care in Managing Symptoms in Participants With Recurrent Stage III-IV Thoracic Malignancie NCT04662645	Ohio State University Comprehensive Cancer Center	N/A
Active Not Recruiting	Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymph NCT02465060	National Cancer Institute (NCI)	Phase 2
Completed	Radiation Therapy and MK-3475 for Patients With Recurrent/Metastatic Head and Neck Cancer, Renal Cell Cancer, NCT02318771	Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University	Phase 1
Completed	Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfun NCT01638533	National Cancer Institute (NCI)	Phase 1
Completed	Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors NCT01522820	Roswell Park Cancer Institute	Phase 1